Quick Read – CVS Health (CVS) posted Q1 adjusted EPS of $2.57, beating consensus by 36%, while Aetna’s health benefits operating income surged 52.6% as the medical benefit ratio improved to 84.6% from 87.3%. – Management raised full-year adjusted EPS guidance to $7.30-$7.50 and…
erating cash flow to at least $9.5 billion. 24/7 Wall St. issued a buy rating with a $125.45 price target, implying 44.43% upside. – Aetna’s margin recovery is executing ahead of plan after the individual exchange exit removes a money-losing segment, while Caremark maintains high-90s client retention and launches Health100 on Google Cloud to drive engagement. – The analyst who called NVIDIA in 2010 just named his top 10 stocks and CVS Health wasn’t one of them. Get them here FREE
Our 24/7 Wall St. price target for CVS Health (NYSE:CVS) is $125.45, pointing to meaningful upside from where shares trade today. The stock closed at $86.86 on May 6, after a 7.65% single-day pop on Q1 earnings. Our model implies 44.43% upside over the next 12 months, and we are issuing a buy rating with high confidence. 24/7 Wall St.
Price Target Summary The analyst who called NVIDIA in 2010 just named his top 10 stocks and CVS Health wasn’t one of them. Get them here FREE. Aetna’s Margin Snapback Just Reset the CVS Story CVS has been one of the strongest large-cap healthcare names of the past year, gaining 35.88% over the last 12 months and 19.53% in just the past month.